- Home
- CTVA vs VTR Comparison
CTVA vs VTR Comparison
Compare CTVA & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTVA | VTR |
|---|---|---|
| Founded | 2018 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Real Estate Investment Trusts |
| Sector | Consumer Staples | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.7B | 36.3B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | CTVA | VTR |
|---|---|---|
| Price | $72.87 | $75.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 13 |
| Target Price | $78.38 | ★ $79.46 |
| AVG Volume (30 Days) | ★ 3.5M | 2.7M |
| Earning Date | 02-03-2026 | 02-05-2026 |
| Dividend Yield | 0.99% | ★ 2.53% |
| EPS Growth | ★ 139.00 | N/A |
| EPS | ★ 2.35 | 0.53 |
| Revenue | ★ $17,469,000,000.00 | $5,544,046,000.00 |
| Revenue This Year | $6.91 | $18.51 |
| Revenue Next Year | $3.56 | $11.29 |
| P/E Ratio | ★ $31.09 | $143.97 |
| Revenue Growth | 5.00 | ★ 16.38 |
| 52 Week Low | $53.40 | $58.72 |
| 52 Week High | $77.41 | $81.89 |
Technical Indicators
Market Signals| Indicator | CTVA | VTR |
|---|---|---|
| Relative Strength Index (RSI) | 69.09 | 41.55 |
| Support Level | $68.42 | $76.04 |
| Resistance Level | $72.30 | $77.32 |
| Average True Range (ATR) | 1.34 | 1.53 |
| MACD | 0.28 | -0.07 |
| Stochastic Oscillator | 90.96 | 43.03 |
Price Performance
Historical ComparisonAbout CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.